Not applicableUnknownNCT06133335What this trial is testingCystic Fibrosis and Periodontal DiseasesWho this might be right forCystic FibrosisPeriodontitisGingivitis CHU de Reims 50
Testing effectiveness (Phase 2)WithdrawnNCT05641298What this trial is testingStudy to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary ExacerbationsWho this might be right forCystic FibrosisCystic Fibrosis Pulmonary Exacerbation Aceragen
Early research (Phase 1)Looking for participantsNCT05988463What this trial is testingDose-Escalation Study of Artesunate Patients With IPFWho this might be right forIdiopathic Pulmonary Fibrosis Joseph C. Wu 15
Not applicableStudy completedNCT00311506What this trial is testingDetermine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung DiseaseWho this might be right forCystic Fibrosis Genentech, Inc. 25
Not applicableUnknownNCT00564304What this trial is testingNPD Measurement in InfantsWho this might be right forCystic Fibrosis Hadassah Medical Organization 50
Not applicableLooking for participantsNCT06883448What this trial is testingImplementation of Home Monitoring in Patients With Pulmonary FibrosisWho this might be right forPulmonary FibrosisInterstitial Lung Disease (ILD) Erasmus Medical Center 220
Not applicableStudy completedNCT00248755What this trial is testingAssessing Mucociliary Clearance and Airway Liquid Volume in the CF AirwayWho this might be right forCystic Fibrosis University of Pittsburgh 14
Not applicableNot Yet RecruitingNCT07722507What this trial is testingAntifibrotic Therapy Decision-Making in Pulmonary FibrosisWho this might be right forPulmonary FibrosisIdiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis Bristol-Myers Squibb 40
Not applicableStudy completedNCT00716664What this trial is testingDo Musculoskeletal Techniques Improve Forced Expiratory Volume in One Second in Adults With Cystic Fibrosis?Who this might be right forCystic Fibrosis Royal Brompton & Harefield NHS Foundation Trust 20
Not applicableStudy completedNCT00308958What this trial is testingComparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic FibrosisWho this might be right forCystic Fibrosis University of Minnesota 15
Not applicableStudy completedNCT00530244What this trial is testingUse of Formula Fortified With DHA in Infants With Cystic FibrosisWho this might be right forCystic Fibrosis University of Massachusetts, Worcester 76
Not applicableUnknownNCT03902236What this trial is testingReaction Time and Postural Control in Individuals With Cystic Fibrosis and BronchiectasisWho this might be right forCystic FibrosisBronchiectasis Hacettepe University 60
Large-scale testing (Phase 3)Study completedNCT01515007What this trial is testingPhase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)Who this might be right forNon Cystic Fibrosis Bronchiectasis Aradigm Corporation 278
Not applicableStudy completedNCT05568134What this trial is testingAlternate Measures of Glucose During OGTT Testing for CFRDWho this might be right forCystic FibrosisCystic Fibrosis-related Diabetes Children's Hospital of Philadelphia 14
Not applicableStudy completedNCT03913507What this trial is testingEfficacy of a New Sweat Collection Support: Impact on Neonatal Screening and Early Treatment of Cystic FibrosisWho this might be right forCystic Fibrosis Cliniques universitaires Saint-Luc- Université Catholique de Louvain 57
Very early researchLooking for participantsNCT07569419What this trial is testingProof of Principle Study for an Efficacy Trial of Linaclotide for Cystic FibrosisWho this might be right forCystic Fibrosis (CF) University of Nottingham 26
Post-approval studies (Phase 4)Not Yet RecruitingNCT07809867What this trial is testingPharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic FibrosisWho this might be right forCystic Fibrosis (CF) Istituto Giannina Gaslini 50
Not applicableStudy completedNCT05779007What this trial is testingDose Reduction and Discontinuation With Anti-Fibrotic MedicationsWho this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim 2,778
Testing effectiveness (Phase 2)Study completedNCT02477709What this trial is testingAssess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 6
Large-scale testing (Phase 3)Study completedNCT02279498What this trial is testingSOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic FibrosisWho this might be right forExocrine Pancreatic InsufficiencyCystic Fibrosis Anthera Pharmaceuticals 128